Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2014 FY- Text added to 2015 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
AbbVie, adalimumab, added, adding, algorithm, Allergan, Amylin, Anderson, arbitrator, Arizona, Asia, assay, Athyrium, attorney, background, Balxalta, bankruptcy, Baxalta, beverage, BioPharma, bococizumab, breaking, cap, carbohydrate, Centre, Classification, condensed, Corrupt, cutpoint, daratumumab, DARZALEX, Eisai, enoxaparin, eribulin, escrow, Esq, estate, exemption, flat, flavor, floor, foregoing, Genoptix, GmbH, Halaven, Harry, hazard, Henderson, HUMIRA, IDE, Imputation, incorrect, incremental, induction, insolvency, investee, Investor, involuntary, IVD, Jeffrey, joint, jointly, KEYTRUDA, Laurie, Leonhardt, LIBOR, Lilly, LLP, LMWH, Lyon, Magnitude, Merck, mesylate, MTD, myeloma, Nanogen, notion, PDA, pembrolizumab, pillar, prominent, prototype, PRSU, ratio, Regenerative, relapsed, Relypsa, repaid, satellite, Science, scoring, Senomyx, Shire, South, Southern, statistically, Stelzer, Subtopic, taste, TE, TNF, transportation, unincorporated, unpaid, Ventana, visitation
Removed:
abnormal, acid, acquiring, acting, ambulatory, analog, analyze, API, Apidra, aspart, Auditor, Bausch, Baxter, Biodel, building, burn, capacity, cathepsin, cellulite, chosen, claiming, comparison, CSII, daily, dermatology, distinct, faster, glucose, glulisine, Humalog, hyaluronic, hypoglycemia, Industrial, infrastructure, John, Lily, lispro, Lomb, Mannkind, MDI, mild, modulate, mutually, Nevada, noncontingent, Nordisk, Novo, Novolog, onset, operational, path, Patton, planning, predecessor, pump, reclassified, reintroduced, rituximab, Sanofi, selecting, Shaffer, showing, spend, staffing
Valuein 2014 FY filing- Value in 2015 FY filing
Original filings
Filing view